Gainers
- Equillium EQ shares are trading higher after the company announced "favorable" topline data from the Type A group of the EQUALISE study in patients with systemic lupus erythematosus.
- Lineage Cell Therapeutics LCTX shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a $6 price target.
- Arcadia Biosciences RKDA shares are trading higher after the company announced better-than-expected Q4 sales results.
- ION Geophysical IO shares are trading higher after the company announced it has now finalized plans to launch the second phase of its North Sea 3D multi-client program.
- MIND Technology MIND shares are trading higher after the company announced that its Seamap unit has entered into a Master Supply Agreement with PGS.
- Bellicum Pharmaceuticals BLCM shares are trading higher after the company reported better-than-expected Q4 EPS results.
- Astrotech ASTC shares are trading higher after the company announced its Technologies subsidiary entered into an agreement with Sanmina Corporation to manufacture its mass spectrometry products.
- Surface Oncology SURF shares are trading higher after the company announced the FDA granted Orphan Drug Designation for SRF617 for the treatment of patients with pancreatic cancer.
- Cleveland-Cliffs CLF shares are trading higher after the company provided updated financial guidance.
- Hydrofarm HYFM shares are trading higher after the company reported Q4 EPS of $0.02, up from $(0.29) year and year and better-than-expected Q4 sales results.
Losers
- ProQR Therapeutics PRQR shares are trading lower after the company announced a proposed underwritten public offering of ordinary shares. No terms were disclosed.
- 9 Meters Biopharma NMTR shares are trading lower the company announced a proposed public offering of common stock. No size was disclosed.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.